Alex Roepers
Atlantic Investment Management
Alex Roepers Eastman Chemical Company stake
total: 128
Atlantic Investment Management EMN trades
- Total transactions:
- 33
- New positions:
- 2
- Sold out:
- 2
- Added:
- 13
- Reduced:
- 16
- Held since:
- 2025 Q1
- Held for:
- 2 quarters
- Latest activity:
- 2025 Q3
According to 2026 Q1 report, Alex Roepers doesn't hold any Eastman Chemical Company (EMN) shares. To date, the estimated cost basis is nearly $88.11 for "buy" trades and estimated average "sell" price is $74.66. Atlantic Investment Management first purchased EMN in 2015 Q4, initially acquiring about 1.71M shares. Alex Roepers later completely sold out the position and invested in Eastman Chemical Company again in 2025 Q1. Since the initial investment in Eastman Chemical Company (EMN), Atlantic Investment Management has made 32 more transactions.
When did Alex Roepers sell Eastman Chemical Company (EMN)?
Alex Roepers sold off the entire Eastman Chemical Company (EMN) position in 2025 Q3.
When did Alex Roepers buy Eastman Chemical Company (EMN)?
Alex Roepers first invested in Eastman Chemical Company (EMN) in 2015 Q4 at the reported quarter-end price of $67.51 per share.
What's the cost basis of Atlantic Investment Management's EMN stake?
The estimated cost basis for Eastman Chemical Company (EMN) stake is around $88.11 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $88.11
- Weighted AVG sell price:
- $74.66
Alex Roepers's historical trades in Eastman Chemical Company
33 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q3
|
0.00%
|
0
|
$74.66
|
|
-100% (-134,710)
|
-5.13%
|
|
2025 Q2
|
5.13%
|
134,710
|
$74.66
|
$10,057,449
|
-46.46% (-116,873)
|
-4.88%
|
|
2025 Q1
|
12.38%
|
251,583
|
$88.11
|
$22,166,978
|
new
|
+12.38%
|
|
2024 Q3
|
0.00%
|
0
|
$97.97
|
|
-100% (-367,857)
|
-16.24%
|
|
2024 Q2
|
16.24%
|
367,857
|
$97.97
|
$36,038,950
|
+0.16% (+600)
|
+0.03%
|
|
2024 Q1
|
16.16%
|
367,257
|
$100.22
|
$36,806,497
|
+0.55% (+2,000)
|
+0.09%
|
|
2023 Q4
|
14.98%
|
365,257
|
$89.82
|
$32,807,384
|
+10.93% (+36,000)
|
+1.48%
|
|
2023 Q3
|
12.59%
|
329,257
|
$76.72
|
$25,260,597
|
-18.17% (-73,100)
|
-2.76%
|
|
2023 Q2
|
16.59%
|
402,357
|
$83.72
|
$33,685,328
|
+10.89% (+39,500)
|
+1.63%
|
|
2023 Q1
|
16.51%
|
362,857
|
$84.34
|
$30,603,359
|
+13.87% (+44,200)
|
+2.01%
|
|
2022 Q4
|
14.05%
|
$81.44
|
+3.81% (+11,697)
|
|||
|
2022 Q3
|
9.85%
|
$71.05
|
-5.49% (-17,847)
|
|||
|
2022 Q2
|
11.05%
|
$89.77
|
+3.47% (+10,890)
|
|||
|
2022 Q1
|
11.36%
|
$112.06
|
-24.79% (-103,461)
|
|||
|
2021 Q4
|
14.10%
|
$120.91
|
+317.38% (+317,378)
|
|||
|
2020 Q1
|
2.63%
|
$46.58
|
-75.78% (-312,864)
|
|||
|
2019 Q4
|
9.69%
|
$79.26
|
-17.87% (-89,830)
|
|||
|
2019 Q3
|
13.03%
|
$73.83
|
-34.61% (-266,126)
|
|||
|
2019 Q2
|
16.11%
|
$77.83
|
+3.44% (+25,541)
|
|||
|
2019 Q1
|
14.41%
|
$75.88
|
+643.28% (+643,279)
|
|||
|
2018 Q4
|
1.92%
|
$73.11
|
-80.76% (-419,655)
|
|||
|
2018 Q3
|
8.34%
|
$95.72
|
-1.71% (-9,066)
|
|||
|
2018 Q2
|
8.19%
|
$99.96
|
-41.65% (-377,386)
|
|||
|
2018 Q1
|
13.16%
|
$105.58
|
-19.57% (-220,506)
|
|||
|
2017 Q4
|
13.68%
|
$92.64
|
-7.49% (-91,224)
|
|||
|
2017 Q3
|
13.72%
|
$90.49
|
-28.42% (-483,508)
|
|||
|
2017 Q2
|
14.68%
|
$83.99
|
+8.82% (+137,915)
|
|||
|
2017 Q1
|
13.19%
|
$80.80
|
+29.06% (+352,035)
|
|||
|
2016 Q4
|
11.26%
|
$75.21
|
-37.97% (-741,631)
|
|||
|
2016 Q3
|
17.26%
|
$67.68
|
+36.37% (+520,865)
|
|||
|
2016 Q2
|
12.59%
|
$67.90
|
-5.09% (-76,827)
|
|||
|
2016 Q1
|
11.89%
|
$72.23
|
-11.79% (-201,725)
|
|||
|
2015 Q4
|
11.93%
|
$67.51
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.